Clovis Oncology, Inc. (CLVS) Position Increased by Schwab Charles Investment Management Inc

Pat Wise
January 14, 2018

Vanguard Group Inc. now owns 3,618,843 shares of the biopharmaceutical company's stock worth $338,831,000 after buying an additional 333,648 shares during the last quarter. The institutional investor held 369,500 shares of the health care company at the end of 2017Q3, valued at $30.45M, down from 666,300 at the end of the previous reported quarter. University Of Notre Dame Du Lac who had been investing in Clovis Oncology Inc for a number of months, seems to be less bullish one the $2.89B market cap company. (NASDAQ:CLVS) traded down $0.92 on Friday, hitting $59.01. State Board of Administration of Florida Retirement System now owns 22,819 shares of the biopharmaceutical company's stock valued at $313,000 after buying an additional 1,693 shares during the period.

Clovis Oncology (NASDAQ:CLVS) last posted its quarterly earnings data on Wednesday, November 1st. It has outperformed by 266.01% the S&P500.

Afam Capital Inc increased its stake in Foot Locker (FL) by 73.43% based on its latest 2017Q3 regulatory filing with the SEC. Pacific Heights Asset Management Llc owns 500,000 shares or 1.04% of their U.S. portfolio. The institutional investor held 1,933 shares of the packaged foods company at the end of 2017Q3, valued at $202,000, down from 6,815 at the end of the previous reported quarter.

The stock increased 0.62% or $0.5 during the last trading session, reaching $80.85. About 617,956 shares traded. It has underperformed by 26.00% the S&P500. It also increased its holding in Lumentum Hldgs Inc by 12,000 shares in the quarter, for a total of 97,300 shares, and has risen its stake in Nvidia Corp (NASDAQ:NVDA).

Investors sentiment increased to 0.83 in Q3 2017. Its down 0.37, from 1.81 in 2017Q2. 35 funds opened positions while 65 raised stakes. Advsr Asset Inc reported 5,229 shares. Fred Alger Mgmt Incorporated stated it has 828,407 shares or 0.32% of all its holdings. Quantitative Inv Management Limited Liability Corporation holds 0.03% of its portfolio in Aspen Technology, Inc. (NYSE:WM) for 58,838 shares. Northwestern Mutual Wealth Comm owns 199 shares or 0% of their United States portfolio. Kingdon Mngmt Ltd invested in 0.84% or 155,962 shares.

Private Capital Advisors Inc. holds 1.2% of its portfolio in Urstadt Biddle Properties Inc. for 161,555 shares. (NYSE:WM) for 150 shares. Emerald Mutual Fund Advisers Trust stated it has 272,813 shares. (NASDAQ:CLVS). Mufg Americas holds 0% or 512 shares in its portfolio.

Among 38 analysts covering Oracle (NYSE:ORCL), 28 have Buy rating, 0 Sell and 10 Hold. Oracle had 103 analyst reports since July 30, 2015 according to SRatingsIntel. On Friday, August 26 the stock rating was initiated by Macquarie Research with "Neutral". The firm has "Buy" rating by Bank of America given on Wednesday, August 2. Goldman Sachs maintained T-Mobile US, Inc. On Wednesday, April 13 the stock rating was downgraded by JP Morgan to "Neutral". The Massachusetts-based Ct Mason has invested 0.67% in the stock. The company was downgraded on Friday, June 10 by Jefferies. FBR Capital maintained the stock with "Mkt Perform" rating in Tuesday, October 25 report. Hood River Capital Management Llc, a Oregon-based fund reported 516,995 shares. (NYSE:WM) on Monday, November 7 to "Overweight" rating. The biopharmaceutical company reported ($1.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.18) by ($0.06). They expect $-1.27 earnings per share, up 30.60% or $0.56 from last year's $-1.83 per share. SJM's profit will be $243.09 million for 14.42 P/E if the $2.14 EPS becomes a reality. After $0.90 actual earnings per share reported by Waste Management, Inc. for the previous quarter, Wall Street now forecasts -7.78% negative EPS growth. $1.45M worth of Clovis Oncology, Inc. BLAIR JAMES C also sold $1.45M worth of Clovis Oncology, Inc. The shares were sold at an average price of $63.70, for a total value of $191,100.00.

Lieutenant Governor Justin Fairfax sworn in
Linda Cunningham from Virginia Beach came with her daughter Lindsay, a Northam campaign volunteer, to the inauguration. Northam said the tradition-bound military academy with a strict honor code continues to help guide his actions.

Karnataka: Eight die in bus accident
The Corporation also awarded silver medal to 82 drivers who have not caused any accident or violated any rules for five years. Revanna expressed shock over the accident and announced Rs 3 lakh compensation to the kin of all the deceased.

Falcons in Philadelphia for NFC playoff game
Ajayi was traded to the Eagles from Miami where he rushed for more than 1,200 yards last season, averaging 4.9 yards per carry. Allowed 1,267 rushing yards (79.2 YPG) in 16 games in '17; allowed 1,652 rushing yards in '16 (103.3 YPG)...

Investors sentiment decreased to 1.44 in Q3 2017. Its down 0.37, from 1.81 in 2017Q2. It worsened, as 48 investors sold Clovis Oncology, Inc. shares while 49 reduced holdings.

A number of hedge funds have recently added to or reduced their stakes in CLVS. 996,610 are held by Redmile Grp Ltd Liability.

ILLEGAL ACTIVITY WARNING: "Clovis Oncology (NASDAQ:CLVS) Receives Daily Media Impact Rating of 0.17" was posted by StockNewsTimes and is owned by of StockNewsTimes. Insmed Inc (NASDAQ:INSM) was raised too. Plante Moran Financial Advsrs, Michigan-based fund reported 57 shares. Alpine Woods Cap Investors Limited Com holds 0.01% or 3,000 shares. Bank of Montreal Can now owns 2,702 shares of the biopharmaceutical company's stock valued at $253,000 after purchasing an additional 2,000 shares during the period. Greenwood Capital Assocs Ltd Llc reported 4,609 shares stake. Focused Wealth Mngmt has invested 0.03% in Clovis Oncology, Inc. Glg Limited Liability Com invested in 27,883 shares or 0.15% of the stock. Raymond James Advisors has invested 0.01% in Clovis Oncology, Inc. (NASDAQ:CLVS). Jpmorgan Chase reported 69,146 shares. Federated Pa stated it has 10,000 shares or 0% of all its holdings. (NASDAQ:CLVS). Group Inc One Trading Lp has invested 0.08% in Clovis Oncology, Inc.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 100% are positive. J. M. Smucker Company had 65 analyst reports since August 19, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Clovis Oncology, Inc.

In other Clovis Oncology news, insider Gillian C. Ivers-Read sold 3,000 shares of the stock in a transaction dated Wednesday, November 15th. Credit Suisse has "Outperform" rating and $41 target.

More recent Clovis Oncology, Inc. The firm earned "Positive" rating on Monday, April 24 by Susquehanna. KeyBanc Capital Markets has "Buy" rating and $6100 target.

Schwab Charles Investment Management Inc. boosted its position in Clovis Oncology, Inc. The firm earned "Buy" rating on Monday, September 18 by Leerink Swann. (NASDAQ:CLVS) on Tuesday, December 20 to "Neutral" rating. (NASDAQ:TMUS) has "Outperform" rating given on Wednesday, February 15 by RBC Capital Markets.

Other reports by

Discuss This Article